Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:45-50
doi: 10.1161/hs0102.101228
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helenius, J.
Right arrow Articles by Tatlisumak, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helenius, J.
Right arrow Articles by Tatlisumak, T.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Lacunes
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2002;33:45.)
© 2002 American Heart Association, Inc.


Original Contributions

Leukoaraiosis, Ischemic Stroke, and Normal White Matter on Diffusion-Weighted MRI

Johanna Helenius, MD; Lauri Soinne, MD; Oili Salonen, MD, PhD; Markku Kaste, MD, PhD Turgut Tatlisumak, MD

From the Departments of Neurology (J.H., L.S., M.K., T.T.) and Radiology (O.S.), Helsinki University Central Hospital, Helsinki, Finland.

Correspondence to Dr Johanna Helenius, Department of Neurology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland. E-mail johanna.helenius{at}hus.fi


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose Leukoaraiosis is a radiological finding of uncertain pathogenesis with bilateral patchy or diffuse areas of hyperintensity of the cerebral white matter (WM) on T2-weighted MRI. Using diffusion-weighted MRI (DWI), we aimed to test (1) whether the average apparent diffusion coefficient (ADCav) values of the regions of leukoaraiosis vary according to the degree of the severity of leukoaraiosis and whether the regions of leukoaraiosis could be distinguished (2) from normal WM or (3) from ischemic strokes of various ages.

Methods We compared 85 patients with leukoaraiosis, 22 healthy subjects with no leukoaraiosis on the conventional MR images, and 10 patients with ischemic strokes serially imaged <6 hours, 24 hours, 1 week, 1 month, and 3 months after stroke onset. All subjects were studied with DWI in 3 orthogonal directions with 2 b values (b=0 and b=1000 s/mm2) at 1.5 T. ADCav values were determined for the regions of leukoaraiosis, ischemic lesions, and normal WM.

Results The more severe the leukoaraiosis was, the higher the ADCav values of the leukoaraiotic regions became. The ADCav values (in 10-3 mm2/s) of the regions of leukoaraiosis (0.92 to 1.27) were significantly higher than that of the normal WM (0.69±0.04) and that of the ischemic strokes at 6 hours (0.38±0.07), 24 hours (0.36±0.10), and 1 week (0.51±0.09). One-month-old ischemic strokes (1.08±0.33) had ADCav values similar to those of leukoaraiotic regions, whereas 3-month-old infarcts (1.59±0.32) showed significantly higher ADCav values than the leukoaraiotic regions.

Conclusions The regions of leukoaraiosis show characteristic changes in ADCav values, and DWI can be used to differentiate acute and chronic ischemic stroke lesions from leukoaraiosis.


Key Words: leukoaraiosis • magnetic resonance imaging, diffusion-weighted • stroke • white matter


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Leukoaraiosis refers to bilateral and either patchy or diffuse areas of hypodensity of the cerebral white matter (WM) on CT or hyperintensity on T2-weighted MRI.1,2 It is a radiological finding that probably is caused by chronic cerebral ischemia, but the pathogenesis and its clinical significance are incompletely understood.2 Some individuals remain asymptomatic for prolonged periods, whereas others develop gait disturbance,3 cognitive impairment,4,5 mood disorders, disability, and even dementia.68 Leukoaraiosis increases overall morbidity and mortality8,9 and enhances the risk for stroke.9 Leukoaraiosis is common, and epidemiological studies demonstrate a high prevalence in subjects >65 years old evaluated by CT or MRI.2,10

Diffusion-weighted MRI (DWI) is useful in detecting focal brain ischemia even in the hyperacute (<6 hours) stage.11 Acute brain ischemia causes a rapid decrease in water diffusion, and ischemic regions appear hyperintense on DW images. The lesions disappear over 5 to 10 days (pseudonormalization) and reappear as hypointense lesions thereafter.11 In addition to acute stroke, DWI may also provide information on the extent and elucidate the mechanism of leukoaraiosis.12 The net diffusion of the water molecules measured from a tissue is referred to as the apparent diffusion coefficient (ADC).13 On DW images, tissues with faster diffusion appear dark and tissues with slower diffusion bright, whereas on ADC maps, the reverse is true. The purposes of this study were to test (1) whether the average ADC (ADCav) values of the regions of leukoaraiosis vary according to the degree of the severity of leukoaraiosis and whether the regions of leukoaraiosis could be identified by the use of DWI and distinguished (2) from the normal WM and (3) from the ischemic strokes of various ages.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subject Characteristics
The study comprised 3 groups of subjects: group 1, 85 subjects with leukoaraiosis (22 healthy subjects [9 men, 13 women] with leukoaraiosis, 53 carotid stenosis patients [33 men, 20 women] with leukoaraiosis, and 10 ischemic stroke patients [5 men, 5 women] with leukoaraiosis); group 2, 22 healthy subjects (12 men, 10 women) with no leukoaraiosis; and group 3, 10 patients (5 men, 5 women) with ischemic strokes serially imaged <6 hours (mean 4.4±1.0 hours, range 2.7 to 5.9 hours, n=10), 24 hours (mean 28±2.7 hours, range 23.8 to 31 hours, n=10), 1 week (mean 6.6±0.6 days, range 5.8 to 7.3 days, n=10), 1 month (mean 33±2.9 days, range 30 to 36 days, n=4), and 3 months (mean 90±5.8 days, range 80 to 95 days, n=6) after the insult.

The 10 ischemic stroke patients in group 3 were the same 10 patients with ischemic stroke and coexisting leukoaraiosis as in group 1. The leukoaraiotic changes in these 10 patients were evaluated on their 24-hour ADCav maps. The infarct volumes measured on 1-week images were 0.016±0.02 L. The infarct characteristics were as follows: Four were cortical, and 6 were subcortical. Four were due to atherosclerosis, 3 were cardioembolic, 2 were caused by small-vessel disease, and in 1 patient the cause could not be determined. Five were left-sided, and 5 were right-sided.

The healthy subjects (22 individuals with leukoaraiosis, 42 to 85 years old [68±9.6 years] and 22 individuals without leukoaraiosis, 52 to 73 years old [60±6.4 years]) were chosen from a strictly healthy population and had no symptoms, signs, or histories of any neurological or systemic disease that might have affected the brain (eg, diabetes, chronic obstructive pulmonary disease, hypertension, or metabolic disorders), nor did they have a family history of dementia or multiple sclerosis. None were taking medication regularly, except for female hormone replacement therapy or topical drug treatment. The healthy subjects with and without leukoaraiosis were not entirely age- and sex-matched, because it was difficult to find absolutely healthy individuals with no leukoaraiosis in the same age group. We have shown, however, that the ADCav values in the cerebral WM do not change with aging and between sexes (0.70±0.03x10-3 mm2/s in 50- to 64-year-old and 0.71±0.04x 10-3 mm2/s in 65- to 85-year-old healthy subjects; 0.70± 0.03x10-3 mm2/s in men and 0.71±0.03x10-3 mm2/s in women; unpublished data, Helenius et al).

In patients with carotid stenosis (group 1), 11 were neurologically healthy, and 42 were symptomatic with transient ischemic attacks (n=35) and/or stroke (lacunar stroke, n=27; cortical infarcts, n=12).

All subjects were white and all except 2 were Finnish in origin. This study was approved by the Ethics Committees of the Departments of Neurology and Radiology, Helsinki University Central Hospital, and was carried out according to the principles of the institutional guidelines and the Declaration of Helsinki. All subjects gave written informed consent before enrollment into the study.

Imaging Techniques
The study was performed with a Siemens Magnetom Vision imager (Siemens Medical Systems) operating at 1.5 T. A standard head coil with standard restraints was used to fix the subject’s head. In addition to axial DW images, conventional fluid-attenuated inversion recovery (FLAIR), T1-, T2-, and proton density–weighted images were obtained. All imaging studies were completed without any adverse effect or complication.

DWI was performed with a spin-echo echo-planar imaging sequence having a repetition time of 4000 ms, an echo time of 103 ms, and a gradient strength of 25 mT/m covering 19 slices 5 mm thick (interslice gap 1.5 mm, field of view 230x230 mm2, and matrix size 96x128 interpolated to 256x256). Diffusion was measured in 3 orthogonal directions (x, y, and z) with 2 b values (b=0 and b=1000 s/mm2). The total acquisition time of the DW images was 20 seconds.

Data Analysis
DW images were transferred to a separate workstation for data analysis. First, the images in the 3 orthogonal directions were coregistered. The natural logarithms of the images were averaged to form a rotationally invariant resultant image. With a linear least-squares regression on a pixel-by-pixel basis, the resultant image and the natural logarithm of the reference T2-weighted image (b=0) were fitted to the b values, where the slope of the fitted line was ADCav. The calculations were performed with a commercially available software program (MatLab, Mathsoft Inc).

Rating Scale for Leukoaraiosis
A neuroradiologist (O.S.) blinded to the clinical data of the subjects evaluated the conventional MR images according to a previously validated rating scale.14,15 Periventricular hyperintensities (PVHs) were classified on the basis of size and shape into 3 groups: PVH-1 (small cap/thin lining, <5 mm, n=47), PVH-2 (large cap/smooth halo, 6 to 10 mm, n=22), and PVH-3 (extending cap/irregular halo, >10 mm, n=16). Hyperintensities (HIs) were classified, on the basis of size and shape, into 5 groups: HI-1 (small focal, <5 mm, n=41), HI-2 (large focal, 6 to 10 mm, n=25), HI-3 (focal confluent, 11 to 25 mm, n=13), HI-4 (diffusely confluent, >25 mm, n=6), and HI-5 (diffuse lesions affecting the majority of WM area, n=0).

Region of Interest Analysis
While drawing the regions of interest (ROIs) on the trace images or on the ADCav maps, we simultaneously located the lesions on the conventional images to avoid mistakes. The ischemic stroke ROIs (n=2 to 6 per subject) were drawn on the trace images, where the acute, 24-hour-old, and 1-week-old lesions could easily be identified, and were subsequently transferred to the equivalent ADCav maps. The 1- and 3-month-old lesions as well as the regions of leukoaraiosis (n=8 to 14 per subject) and the normal WM ROIs (n=4 per subject) were drawn directly to the ADCav maps (Figure 1). The normal WM ROIs were the frontal and occipital WM from both hemispheres. Contamination of the normal WM ROIs with the regions of leukoaraiosis was carefully avoided. In each ROI, the surface area was measured, and the mean, SD, and range of the ADCav values were obtained. The ROI analysis was performed with a commercially available image analysis software (Alice, Hayden Image Processing Group, Perceptive Systems Inc).



View larger version (87K):
[in this window]
[in a new window]
 
Figure 1. ROIs used in the leukoaraiosis and normal WM analysis are superimposed on the axial ADCav maps. A, PVHs of the cerebral WM in a male subject from PVH-3. B, HIs of the cerebral WM in a female subject from HI-3. C, Normal WM regions: left and right frontal and occipital WM.

Statistical Analysis
The ADCav values of leukoaraiosis, ischemic stroke, and normal WM were compared by Kruskal-Wallis 1-way ANOVA, as well as the groups of varying degrees of leukoaraiosis and stroke. Groupwise comparison between any 2 groups was made by use of the Mann-Whitney U test. Comparison between hemispheres in carotid stenosis patients was made by paired t test. A 2-tailed value of P<0.05 was considered significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
All ADCav values are given as x10-3 mm2/s. The ADCav values of the leukoaraiotic regions and the normal WM of all subjects in group 1 are presented in the Table. The correlation of the ADCav values with the severity of leukoaraiosis is presented in Figure 2.


View this table:
[in this window]
[in a new window]
 
Table 1. ADCav Values of Leukoaraiotic Regions of Different Degrees of Leukoaraiosis in All Subjects, in Healthy Volunteers With Leukoaraiosis, in Carotid Stenosis Patients With Leukoaraiosis, and in Stroke Patients With Leukoaraiosis (Group 1)



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Evaluation of ADCav values. A, ADCav values of the regions of leukoaraiosis in PVH groups; B, ADCav values of the regions of leukoaraiosis in HI groups; C, ADCav values of ischemic strokes of different stages; D, normal WM ADCav values in PVH groups; and E, normal WM ADCav values in HI groups.

As the leukoaraiosis increased (PVH-1 to -3 and HI-1 to -4), the ADCav values showed a directly proportional increase (P<0.01 for both PVH and HI) (Figure 2, A and B).

The ADCav values of the normal WM of the subjects with leukoaraiosis (group 1 as a whole) did not differ from those of the healthy subjects with no leukoaraiosis (mean 0.69±0.04, range 0.63 to 0.75) (group 2). With more detailed analysis within group 1, however, the ADCav values of the normal WM varied according to the degree of the severity of leukoaraiosis, being highest in the most severely leukoaraiotic groups (Figure 2, D and E; P<0.01 for all). In patients with carotid stenosis, the ADCav values of the normal WM between the stenotic and the nonstenotic sides were slightly but significantly different from each other (mean 0.70±0.04, range 0.61 to 0.81, versus mean 0.69±0.05, range 0.55 to 0.78, P<0.05, respectively). Instead, the ADCav values of the leukoaraiotic regions were not different between brain hemispheres in these patients (mean 0.95±0.12, range 0.81 to 1.31, versus mean 0.95±0.11, range 0.81 to 1.31, P=1.0).

The regions of leukoaraiosis showed significantly higher ADCav values than the normal WM of the same group (group 1, n=85, P<0.01) or than the normal WM of group 2 (n=22, healthy subjects with no leukoaraiosis, mean 0.69±0.04, range 0.63 to 0.75, P<0.01) (Table).

The ADCav values of the ischemic strokes at the hyperacute stage (mean 0.38±0.07, range 0.25 to 0.49, n=10), the 24-hour stage (mean 0.36±0.10, range 0.21 to 0.55, n=10), and the 1-week stage (mean 0.51±0.09, range 0.35 to 0.62, n=10) were significantly lower than the ADCav values of the regions of leukoaraiosis (P<0.01 for all) (Figure 2, A, B, and C). At 1 month, the ischemic lesions showed ADCav values (mean 1.08±0.33, range 0.61 to 1.32, n=4) similar to those of the regions of leukoaraiosis. Instead, at the chronic stage (3 months), the ischemic lesions had significantly higher ADCav values (mean 1.59±0.32, range 1.27 to 1.97, n=6) than the regions of leukoaraiosis (P<0.01).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
Bilateral, patchy, and diffuse areas of hyperintensity of the cerebral WM on T2-weighted MRI, referred to as leukoaraiosis, were found to be hyperintense on the ADCav maps in this study and in a previous report.12 Leukoaraiosis is characterized with axonal loss and proliferation of glial cells.2 Especially axonal loss may contribute to ADC increase, because axons produce significant hindrance to water diffusion. Axonal loss, furthermore, leads to an increase in water content of the tissue. A previous study with a small number of patients16 has shown a decrease in fractional anisotropy in the regions of leukoaraiosis and an increase in ADC values similar to our results.

The more severe the leukoaraiosis was, the higher the ADCav values of the leukoaraiotic regions became. This finding was surprising and novel. Presumably, the cause and pathogenesis of leukoaraiosis may contribute to this finding. Numerous potential factors have been suggested to contribute to the pathogenesis,1,2 chronic hypoperfusion being the most popular hypothesis. Leukoaraiosis is known to increase with age even in neurologically healthy subjects.6,17,18 Failure of blood supply,1921 ischemia,22 and blood pressure dysregulation6,15,2325 also induce leukoaraiosis. Disturbed flow of cerebrospinal fluid is known to increase periventricular WM changes,20 and leukoaraiosis is found in Alzheimer’s disease, in vascular dementia,26 and in many hereditary diseases, including CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy).6 In autopsy studies, periventricular venous collagenosis, perivascular degeneration,27 lacunar infarcts, incomplete infarctions, and gliosis have been found to be associated with leukoaraiosis.2,28,29 Despite the large number of studies, the cause and pathogenesis of leukoaraiosis remain controversial. As discussed above, however, axonal loss is likely to contribute to ADC increase, and in severe leukoaraiosis, axonal loss replaced by interstitial water may be remarkably high, which may explain our finding.

The findings that the ADCav values of the normal WM increased from the mildest to the most severe degrees of leukoaraiosis and that the ADCav values of the normal WM in carotid stenosis patients between the stenotic and nonstenotic sides were different may indicate that the WM is already undergoing changes toward leukoaraiosis before it can be detected on the conventional MR images. Because we delineated the normal WM ROIs with great care, it is most unlikely that there was contamination from tissues with leukoaraiosis. Therefore, a partial-volume effect was excluded. DWI may provide information on the extent and severity of leukoaraiosis, and it may detect areas of WM that, even though they appear normal on conventional MRI, are prone to undergo leukoaraiotic change over time. A follow-up study in the future may confirm this finding.

Because a rapid decrease of 30% to 40% in ADC values occurs in acute brain ischemia,11,30 hyperacute and acute ischemic lesions of the brain appear hypointense on ADCav maps.3133 As expected, we could easily distinguish ischemic strokes during the first week from the regions of leukoaraiosis on the ADCav maps. The ADC values of chronic (>3-month-old) brain infarcts are higher than those of the normal brain tissue, because diffusion in necrotic regions approaches that of free water (a mean ADCav value for the lateral ventricles is 2.9±0.22, ranging from 1.7x10-3 to 3.2x10-3 mm2/s; unpublished data, Helenius et al). Not surprisingly, the ADCav values in the regions of leukoaraiosis were lower than those of chronic infarction. It seems that DWI is useful in distinguishing ischemic stroke lesions of the acute and of the chronic stage from the regions of leukoaraiosis. Because the ADCav values of 1-month-old infarcts and leukoaraiotic regions were similar, DWI appeared not to be useful in distinguishing leukoaraiosis from brain infarction at that time point. Even though the patient numbers in the 1- (n=4) and 3-month-old (n=6) infarcts were small, the results of 3 previous studies agree well with our findings of the ADC values in chronic ischemia31,34,35 and further support our findings.

Classification of leukoaraiosis is a challenge. Several rating scales with various approaches have been designed. Some make a distinction between different regions, whereas others use an overall estimate of leukoaraiosis. The scales often refer to definite pulse sequences. We preferred to use a previously validated rating scale developed at our hospital14,15,36 and evaluated leukoaraiosis on T2-weighted, proton density–weighted, and FLAIR images separately in all WM areas and periventricular and other regions.14,36 Our scale has the advantage of taking into account the number, size, and shape of the leukoaraiotic lesions.

In this study, to characterize the ADCav values of leukoaraiosis, we compared spin-echo echo-planar DWI findings of 85 subjects with leukoaraiosis, 22 healthy control subjects without leukoaraiosis, and 10 patients with ischemic strokes serially imaged from the hyperacute to the chronic stage. Apart from being different from the normal WM, the ADCav values of the leukoaraiotic regions showed a consistent trend of an increase in proportion to the severity of the leukoaraiotic change. In the course of ischemic stroke, the evolution of the ADCav values remained below that of the leukoaraiotic regions at the hyperacute and subacute stages up to 1 week, equaled them at 1 month, and significantly exceeded them at 3 months. In conclusion, the regions of leukoaraiosis show characteristic changes in ADCav values, and DWI can be used to differentiate acute and chronic ischemic stroke lesions from leukoaraiosis.


*    Acknowledgments
 
This study was supported in part by the Maire Taponen Foundation, the Finnish Medical Foundation, and the University of Helsinki, all located in Helsinki, Finland. We thank Jussi Perkiö, MSc, Aki Kangasmäki, PhD, and Richard A.D. Carano, PhD, for their assistance in technical and methodological issues.

Received August 10, 2001; revision received September 20, 2001; accepted October 10, 2001.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report: a review. Stroke. 1995; 26: 1293–1301.[Abstract/Free Full Text]

2. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997; 28: 652–659.[Abstract/Free Full Text]

3. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry. 1999; 67: 658–660.[Abstract/Free Full Text]

4. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol. 1993; 50: 818–824.[Abstract/Free Full Text]

5. Tarvonen-Schröder S, Röyttä M, Räihä I, Kurki T, Rajala T, Sourander L. Clinical features of leuko-araiosis. J Neurol Neurosurg Psychiatry. 1996; 60: 431–436.[Abstract/Free Full Text]

6. van Gijn J. Leukoaraiosis and vascular dementia. Neurology. 1998; 51 (suppl 3): 3–8.

7. Yamauchi H, Fukuyama H, Shio H. Corpus callosum atrophy in patients with leukoaraiosis may indicate global cognitive impairment. Stroke. 2000; 31: 1515–1520.[Abstract/Free Full Text]

8. Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology. 2000; 54: 90–94.[Abstract/Free Full Text]

9. Inzitari D, Cadelo M, Marranci ML, Pracucci G, Pantoni L. Vascular deaths in elderly neurological patients with leukoaraiosis. J Neurol Neurosurg Psychiatry. 1997; 62: 177–181.[Abstract/Free Full Text]

10. Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology. 1997; 39: 537–545.[CrossRef][Medline] [Order article via Infotrieve]

11. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995; 37: 231–241.[CrossRef][Medline] [Order article via Infotrieve]

12. Okada K, Wu LH, Kobayashi S. Diffusion-weighted MRI in severe leukoaraiosis. Stroke. 1999; 30: 478–479[letter].[Free Full Text]

13. Le Bihan D, Breton E, Lallemand D, Grenier P, Canabis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurological disorders. Radiology. 1986; 161: 401–407.[Abstract/Free Full Text]

14. Mäntylä R, Aronen HJ, Salonen O, Korpelainen M, Peltonen T, Standertskjöld-Nordenstam C, Erkinjuntti T. The prevalence and distribution of white-matter changes on different MRI pulse sequences in a post-stroke cohort. Neuroradiology. 1999; 41: 657–665.[CrossRef][Medline] [Order article via Infotrieve]

15. Mäntylä R, Aronen HJ, Salonen O, Pohjasvaara T, Korpelainen M, Peltonen T, Standertskjöld-Nordenstam CG, Kaste M, Erkinjuntti T. Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke. 1999; 30: 2053–2058.[Abstract/Free Full Text]

16. Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SC, Markus HS. Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke. 1999; 30: 393–397.[Abstract/Free Full Text]

17. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol. 1997; 56: 1269–1275.[Medline] [Order article via Infotrieve]

18. Longstreth WT Jr, Diehr P, Manolio TA, Beauchamp NJ, Jungreis CA, Lefkowitz D. Cluster analysis and patterns of findings on cranial magnetic resonance imaging of the elderly: the Cardiovascular Health Study. Arch Neurol. 2001; 58: 635–640.[Abstract/Free Full Text]

19. Wiszniewska M, Devuyst G, Bogousslavsky J, Ghika J, van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke? Arch Neurol. 2000; 57: 967–973.[Abstract/Free Full Text]

20. Oishi M, Mochizuki Y. Regional cerebral blood flow and cerebrospinal fluid glutamate in leukoaraiosis. J Neurol. 1998; 245: 777–780.[CrossRef][Medline] [Order article via Infotrieve]

21. Markus HS, Lythgoe DJ, Østergaard L, O’Sullivan M, Williams SC. Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI. J Neurol Neurosurg Psychiatry. 2000; 69: 48–53.[Abstract/Free Full Text]

22. Yamauchi H, Fukuyama H, Nagahama Y, Shiozaki T, Nishizawa S, Konishi J, Shio H, Kimura J. Brain arteriolosclerosis and hemodynamic disturbance may induce leukoaraiosis. Neurology. 1999; 53: 1833–1838.[Abstract/Free Full Text]

23. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol. 1990; 11: 273–281.[Abstract]

24. Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, Ozawa T. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke. 1997; 28: 2169–2173.[Abstract/Free Full Text]

25. Shintani S, Shiigai T, Arinami T. Silent lacunar infarction on magnetic resonance imaging (MRI): risk factors. J Neurol Sci. 1998; 160: 82–86.[CrossRef][Medline] [Order article via Infotrieve]

26. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O’Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 1999; 52: 1153–1158.[Abstract/Free Full Text]

27. Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology. 1995; 194: 469–476.[Abstract/Free Full Text]

28. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Alterations in glia and axons in the brains of Binswanger’s disease patients. Stroke. 1997; 28: 1423–1429.[Abstract/Free Full Text]

29. Murdoch G. Staining for apoptosis: now neuropathologists can "see" leukoaraiosis. AJNR Am J Neuroradiol. 2000; 21: 42–43.[Free Full Text]

30. Li F, Han SS, Tatlisumak T, Liu KF, Garcia JH, Sotak CH, Fisher M. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol. 1999; 46: 333–342.[CrossRef][Medline] [Order article via Infotrieve]

31. Weber J, Mattle HP, Heid O, Remonda L, Schroth G. Diffusion-weighted imaging in ischaemic stroke: a follow-up study. Neuroradiology. 2000; 42: 184–191.[CrossRef][Medline] [Order article via Infotrieve]

32. Singer MB, Chong J, Lu D, Schonewille WJ, Tuhrim S, Atlas SW. Diffusion-weighted MRI in acute subcortical infarction. Stroke. 1998; 29: 133–136.[Abstract/Free Full Text]

33. Oliveira-Filho J, Ay H, Schaefer PW, Buonanno FS, Chang Y, Gonzalez RG, Koroshetz WJ. Diffusion-weighted magnetic resonance imaging identifies the "clinically relevant" small-penetrator infarcts. Arch Neurol. 2000; 57: 1009–1014.[Abstract/Free Full Text]

34. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology. 1996; 199: 403–408.[Abstract/Free Full Text]

35. Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology. 1997; 49: 113–119.[Abstract/Free Full Text]

36. Mäntylä R, Erkinjuntti T, Salonen O, Aronen HJ, Peltonen T, Pohjasvaara T, Standertskjöld-Nordenstam CG. Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke. 1997; 28: 1614–1623.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
RadiologyHome page
N. Altaf, P. S. Morgan, A. Moody, S. T. MacSweeney, J. R. Gladman, and D. P. Auer
Brain White Matter Hyperintensities Are Associated with Carotid Intraplaque Hemorrhage
Radiology, July 1, 2008; 248(1): 202 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J H Fu, C Z Lu, Z Hong, Q Dong, Y Luo, and K S Wong
Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 793 - 796.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Schmidt, Ph. Scheltens, T. Erkinjuntti, L. Pantoni, H. S. Markus, A. Wallin, F. Barkhof, and F. Fazekas
White matter lesion progression: A surrogate endpoint for trials in cerebral small-vessel disease
Neurology, July 13, 2004; 63(1): 139 - 144.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Soinne, J. Helenius, E. Saimanen, O. Salonen, P. J. Lindsberg, M. Kaste, and T. Tatlisumak
Brain diffusion changes in carotid occlusive disease treated with endarterectomy
Neurology, October 28, 2003; 61(8): 1061 - 1065.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Firbank, T. Minett, and J. T. O'Brien
Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects
Neurology, October 14, 2003; 61(7): 950 - 954.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. O'Sullivan, P. M. Rich, T. R. Barrick, C. A. Clark, and H. S. Markus
Frequency of Subclinical Lacunar Infarcts in Ischemic Leukoaraiosis and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1348 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
U G R Schulz, D Briley, T Meagher, A Molyneux, and P M Rothwell
Abnormalities on diffusion weighted magnetic resonance imaging performed several weeks after a minor stroke or transient ischaemic attack
J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 734 - 738.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Mascalchi, M. Moretti, R. Della Nave, F. Lolli, C. Tessa, G. Carlucci, L. Bartolini, G. Pracucci, L. Pantoni, M. Filippi, et al.
Longitudinal evaluation of leukoaraiosis with whole brain ADC histograms
Neurology, September 24, 2002; 59(6): 938 - 940.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helenius, J.
Right arrow Articles by Tatlisumak, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helenius, J.
Right arrow Articles by Tatlisumak, T.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Cerebral Lacunes
Right arrow Computerized tomography and Magnetic Resonance Imaging